Charles Divita III Sells 19,132 Shares of Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) CEO Charles Divita III sold 19,132 shares of the firm’s stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $145,977.16. Following the transaction, the chief executive officer directly owned 389,894 shares of the company’s stock, valued at approximately $2,974,891.22. This trade represents a 4.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Charles Divita III also recently made the following trade(s):

• On Wednesday, March 11th, Charles Divita III sold 27,731 shares of Teladoc Health stock. The stock was sold at an average price of $5.49, for a total transaction of $152,243.19.

Teladoc Health Stock Up 2.8%

TDOC stock opened at $7.29 on Friday. The stock has a market capitalization of $1.32 billion, a P/E ratio of -7.51 and a beta of 2.14. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.72 and a current ratio of 2.80. Teladoc Health, Inc. has a one year low of $4.40 and a one year high of $9.77. The company has a 50 day moving average price of $6.17 and a two-hundred day moving average price of $6.22.

Teladoc Health (NYSE:TDOC) last released its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.01). The business had revenue of $613.85 million during the quarter, compared to analyst estimates of $611.04 million. Teladoc Health had a negative net margin of 6.81% and a negative return on equity of 11.45%. The business’s revenue for the quarter was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. As a group, sell-side analysts expect that Teladoc Health, Inc. will post -0.91 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. BMO Capital Markets dropped their target price on Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a research note on Thursday, February 26th. Canaccord Genuity Group lowered their price objective on shares of Teladoc Health from $12.00 to $10.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Deutsche Bank Aktiengesellschaft raised shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 price objective for the company in a research note on Tuesday, March 10th. Barclays lowered their price objective on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research note on Thursday, March 26th. Finally, Leerink Partners lowered their price objective on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a research note on Thursday, February 26th. Five analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Teladoc Health has an average rating of “Hold” and an average price target of $7.43.

Hedge Funds Weigh In On Teladoc Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Essential Partners LLC acquired a new position in shares of Teladoc Health during the 1st quarter valued at $113,000. Janus Henderson Group PLC lifted its holdings in shares of Teladoc Health by 7.7% during the 1st quarter. Janus Henderson Group PLC now owns 262,215 shares of the health services provider’s stock valued at $1,429,000 after acquiring an additional 18,679 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Teladoc Health by 694.5% during the 1st quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after acquiring an additional 4,945 shares in the last quarter. California State Teachers Retirement System lifted its holdings in shares of Teladoc Health by 61.2% during the 1st quarter. California State Teachers Retirement System now owns 274,441 shares of the health services provider’s stock valued at $1,496,000 after acquiring an additional 104,160 shares in the last quarter. Finally, Quantinno Capital Management LP lifted its holdings in shares of Teladoc Health by 128.0% during the 1st quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after acquiring an additional 1,471,631 shares in the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.